Novel Passive Implantable Atrial Defibrillator Using Transcutaneous Radiofrequency Energy Transmission Successfully Cardioverts Atrial Fibrillation
Authors:
Open Access
- 16 September 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 108 (11) , 1382-1388
Abstract
Background— Conventional methods for cardioversion of atrial fibrillation (AF) to sinus rhythm have numerous difficulties. A novel method for cardioversion using the passive implantable atrial defibrillator (PIAD) was tested in acute animal models. This device does not have a battery or a capacitor to store energy and is activated by transferring RF energy across the skin from an external transmitter to the subcutaneously implanted defibrillator. On activation, a novel monophasic shock waveform with 5% tilt is delivered to the heart via 2 intracardiac defibrillation leads. Methods and Results— Cardioversion attempts with the device were assessed in 2 phases: a feasibility and efficacy study and randomized comparison against standard waveforms. Defibrillation leads were placed transvenously into the distal coronary sinus and the right atrial appendage. These were connected to the subcutaneously implanted PIAD. Sustained AF was induced by rapid atrial pacing. The transmitter coil was placed on the skin overlying the defibrillator, and defibrillation synchronized to the R wave was attempted. The method was found to be efficacious at very low voltage and energy, with 100% cardioversion success observed for 10-ms 100-V shocks (mean energy, 1.54±0.02 J). The PIAD waveform had a higher cardioversion success rate than a truncated, 70% tilt monophasic exponential pulse (100 V, 100% versus 78.0±7.57%; P =0.001). There were no postshock complications. Conclusions— Considering these animal results, this method is promising for cardioverting AF in symptomatic patients.Keywords
This publication has 22 references indexed in Scilit:
- Multicenter Low Energy Transvenous Atrial Defibrillation (XAD) Trial Results in Different Subsets of Atrial FibrillationJACC, 1997
- Testing different biphasic waveforms and capacitances: Effect on atrial defibrillation threshold and pain perceptionJACC, 1996
- Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humansJACC, 1995
- Initial Experience with Intracardiac Atrial Defibrillation in Patients with Chronic Atrial FibrillationPacing and Clinical Electrophysiology, 1994
- Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: Evidence for “atrial stunning” as a mechanism of thromboembolic complicationsJACC, 1994
- Low energy synchronous transcatheter cardioversion of atrial flutter/fibrillation in the dogJACC, 1990
- High-efficiency coupling-insensitive transcutaneous power and data transmission via an inductive linkIEEE Transactions on Biomedical Engineering, 1990
- Metabolic Changes and Mitochondrial Dysfunction Early Following Transthoracic Countershock in DogsPacing and Clinical Electrophysiology, 1989
- Death and damage caused by multiple direct current shocks: studies in an animal modelEuropean Heart Journal, 1988
- Analysis of resonant coupled coils in the design of radio frequency transcutaneous linksMedical & Biological Engineering & Computing, 1983